GlaxoSmithKline Pharmaceuticals Limited — Others, 30-10-2024: Copy of Newspaper Publication

GlaxoSmithKline Pharmaceuticals Limited announced the publication of its un-audited financial results for the quarter and half-year ended September 30, 2024. The company reported revenue of ₹1000 crore and a net profit of ₹248.69 lakh. Additionally, a special interim dividend of ₹12 per equity share has been declared. This information has been disseminated through advertisements in major publications, complying with regulatory requirements.